Cardiology and Heart Surgery
Featured Content |VIEW MORE
News
Case Report Highlights Heart Transplant for Complex Fontan Patient
This case demonstrates that even patients with highly complex congenital heart disease can safely undergo heart transplantation, offering a life-saving option when Fontan palliation is no longer sufficient.
News
Study Examines Surgery vs. Surveillance for Vascular Rings
A recent study from Phoenix Children’s cardiologists and cardiothoracic surgeons examines how best to manage children with vascular rings, comparing surgical treatment with observation over time.
News
Factors That Impact SCPC Outcomes
A recent review led by Arash Sabati, MD, a cardiologist with Phoenix Children's, explores the superior cavopulmonary connection (SCPC), a key procedure for children with.
News
Phoenix Children’s Earns National Designation for Pediatric Pulmonary Hypertension Care
Phoenix Children’s is now designated a PPHNet Network Site one of only 14 pediatric centers in the US and Canada, recognized for excellence in pediatric pulmonary hypertension care.
News
First and only center in Arizona to receive highest designation for advanced life support
Phoenix Children’s has been recognized with the prestigious ELSO Award for Excellence in Life Support, achieving Platinum Center of Excellence status from the Extracorporeal Life Support Organization (ELSO).
News
A newly published article in JTCVS Techniques presents an innovative cardiothoracic surgical approach focused on addressing a specific technical challenge while supporting efficiency and reproducibility in the operating room.
News
A recent American College of Cardiology expert analysis reviews surgical systemic vein (innominate vein) turndown as a promising treatment for protein?losing enteropathy (PLE) in patients with Fontan circulation.
News
National Leadership in Fontan Outcomes Research
A landmark study led by Phoenix Children’s Dr. Deepti Bhat and collaborators has been published in Circulation, one of the most highly regarded and influential journals in cardiovascular medicine.
News
Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy
First-in-class drug brightens outlook for those diagnosed with hypertrophic cardiomyopathy in childhood
